Medicinal Chemistry Research Group
Research Centre for Natural Sciences, Budapest


New process chemistry grant received
Ministry for National Economy announced that the project entitled „Green chemistry processes for the intermediers of new, innovative agrochemicals at KISCHEMICALS” (GINOP-2.2.1-15/55) has been granted for the consortium of our group and KISCHEMICALS Ltd (KCH). KCH is involved in the production and trading of agrochemical intermediates and active ingredients. Based on our process chemistry expertise we join KCH to widen its product portfolio. The grant allows us to open a new lab at the Pannon University, Veszprém.

API process development with EGIS
National Office of Research, Development and Innovation announced that the project entitled „Research and development of innovative, value added APIs and formulated products for cardiovascular, oncological and CNS diseases” (KFI_16-1-2017-0170) has been granted for EGIS Pharmaceuticals, a member of Servier. Based on the long term partnership with EGIS our group is involved in the process chemistry activity of the project.

Visiting researcher
It is our pleasure to welcome Moira Rachman from the University of Barcelona for three months. Moira will work on the fragment-based design of novel JAK inhibitors.

Developing new chemistries for pharma research with Mcule
European Commission announced that the project entitled ”Building the Ultimate chemical database for drug discovery” of Mcule, a Hungary based company operating the world’s largest chemical web-shop. Under the H2020 SME Instruments Phase 2 grant (H2020-SMEINST-2-2016-2017) our group receives financial support from Mcule to develop new chemistries for pharma research. This collaboration opens the opportunity to commercialize our scaffolds and libraries to Mcule customers.

New colleague
We are happy to welcome our newest group member, Helga Bereczki, who will work on synthetic and analytical chemistry.

Grant for a new LC-MS/MS instrument received
Ministry for National Economy announced that our group, in consortium with three further RCNS labs won the research infrastructure grant (VEKOP-2.3.3-15-2016-00011) that allows us to install a new LC-MS/MS at our lab.

Visiting researcher
We are happy to welcome back Krzysztof Rataj from the Polish Academy of Sciences (Warsaw, Poland), who will collaborate with us in GPCR-directed computational drug discovery.

National Competitiveness and Excellence Program (NVKP) finances a new oncology program in our group
Joining our expertise with FOTOTRONIC Ltd, a member of the Rasopathy consortium (NVKP_16-1-2016-0020) we started a new oncology program aiming the development of KRAS inhibitors. The collaboration is based on the rapidly developing covalent drug discovery platform of our group.

View archived news